These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

20 related articles for article (PubMed ID: 16027041)

  • 1. CD8(+) T lymphocytes isolated from renal cancer patients recognize tumour cells through an HLA- and TCR/CD3-independent pathway.
    Lionello I; Mangia P; Gattinoni L; Pende D; Cippone A; Sensi M; Rigatti P; Traversari C
    Cancer Immunol Immunother; 2007 Jul; 56(7):1065-76. PubMed ID: 17195078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of asbestos exposure on differentiation and function of cytotoxic T lymphocytes.
    Kumagai-Takei N; Nishimura Y; Maeda M; Hayashi H; Matsuzaki H; Lee S; Yoshitome K; Ito T; Otsuki T
    Environ Health Prev Med; 2020 Oct; 25(1):59. PubMed ID: 33032525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional properties of CD8(+) lymphocytes in patients with pleural plaque and malignant mesothelioma.
    Kumagai-Takei N; Nishimura Y; Maeda M; Hayashi H; Matsuzaki H; Lee S; Kishimoto T; Fukuoka K; Nakano T; Otsuki T
    J Immunol Res; 2014; 2014():670140. PubMed ID: 25045719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene expression profile of peripheral blood lymphocytes from renal cell carcinoma patients treated with IL-2, interferon-α and dendritic cell vaccine.
    Wolf B; Schwarzer A; Côté AL; Hampton TH; Schwaab T; Huarte E; Tomlinson CR; Gui J; Fisher JL; Fadul CE; Hamilton JW; Ernstoff MS
    PLoS One; 2012; 7(12):e50221. PubMed ID: 23226513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and immunologic effects of intranodal autologous tumor lysate-dendritic cell vaccine with Aldesleukin (Interleukin 2) and IFN-{alpha}2a therapy in metastatic renal cell carcinoma patients.
    Schwaab T; Schwarzer A; Wolf B; Crocenzi TS; Seigne JD; Crosby NA; Cole BF; Fisher JL; Uhlenhake JC; Mellinger D; Foster C; Szczepiorkowski ZM; Webber SM; Schned AR; Harris RD; Barth RJ; Heaney JA; Noelle RJ; Ernstoff MS
    Clin Cancer Res; 2009 Aug; 15(15):4986-92. PubMed ID: 19622576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Numbers matter: quantitative and dynamic analysis of the formation of an immunological synapse using imaging flow cytometry.
    Ahmed F; Friend S; George TC; Barteneva N; Lieberman J
    J Immunol Methods; 2009 Aug; 347(1-2):79-86. PubMed ID: 19524586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T cell functions of IL-2-activated tumor-infiltrating lymphocytes from renal cell carcinoma.
    Morita T; Salmeron MA; Hayakawa K; Swanson DA; von Eschenbach AC; Itoh K
    Reg Immunol; 1992; 4(4):225-35. PubMed ID: 1476875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heteroconjugate antibody-directed killing of autologous human renal carcinoma cells by in vitro-activated lymphocytes.
    Kerr L; Huntoon C; Donohue J; Leibson PJ; Bander NH; Ghose T; Luner SJ; Vessella R; McKean DJ
    J Immunol; 1990 May; 144(10):4060-7. PubMed ID: 2139677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Superior antitumor in vitro responses of allogeneic matched sibling compared with autologous patient CD8+ T cells.
    Kausche S; Wehler T; Schnürer E; Lennerz V; Brenner W; Melchior S; Gröne M; Nonn M; Strand S; Meyer R; Ranieri E; Huber C; Falk CS; Herr W
    Cancer Res; 2006 Dec; 66(23):11447-54. PubMed ID: 17145892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemokine receptors expression and migration potential of tumor-infiltrating and peripheral-expanded Vgamma9Vdelta2 T cells from renal cell carcinoma patients.
    Viey E; Lucas C; Romagne F; Escudier B; Chouaib S; Caignard A
    J Immunother; 2008 Apr; 31(3):313-23. PubMed ID: 18317356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor cells regulate the lytic activity of tumor-specific cytotoxic t lymphocytes by modulating the inhibitory natural killer receptor function.
    Gati A; Guerra N; Giron-Michel J; Azzarone B; Angevin E; Moretta A; Chouaib S; Caignard A
    Cancer Res; 2001 Apr; 61(8):3240-4. PubMed ID: 11309272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired cytolytic activity in peripheral blood T cells from renal cell carcinoma patients.
    Crocenzi TS; Tretter CP; Schwaab T; Schned AR; Heaney JA; Cole BF; Fisher JL; Ernstoff MS
    Clin Immunol; 2005 Oct; 117(1):6-11. PubMed ID: 16027041
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 1.